Initial Management of Insomnia
Cognitive Behavioral Therapy for Insomnia (CBT-I) should be recommended as the first-line treatment for all adult patients presenting with chronic insomnia. 1, 2
Assessment and Diagnosis
Before initiating treatment, evaluate for:
- Duration and pattern of sleep disturbance
- Daytime symptoms and impairment
- Sleep habits and environment
- Comorbid medical or psychiatric conditions
- Current medications that may affect sleep
- Use of standardized tools like Insomnia Severity Index or Pittsburgh Sleep Quality Index 2
First-Line Treatment: CBT-I
CBT-I is strongly recommended by the American College of Physicians with moderate-quality evidence supporting its efficacy 1. It consists of several components:
- Cognitive therapy: Identifying and challenging dysfunctional beliefs about sleep
- Sleep restriction: Limiting time in bed to increase sleep efficiency
- Stimulus control: Using the bedroom only for sleep and sex
- Sleep hygiene education: Teaching good sleep habits
- Relaxation techniques: Progressive muscle relaxation, guided imagery, diaphragmatic breathing
Implementation of CBT-I
- Can be delivered through various methods: individual/group therapy, telephone/web-based modules, or self-help books 1
- Typically involves 4-8 weekly sessions of 60-90 minutes 3
- Produces reliable and durable improvements in sleep parameters with 70-80% of patients benefiting from treatment 4
Benefits of CBT-I
- Improves global outcomes including increased remission and treatment response
- Reduces Insomnia Severity Index and Pittsburgh Sleep Quality Index scores
- Decreases sleep onset latency and wake time after sleep onset
- Improves sleep efficiency and quality 1
- Provides sustained benefits for at least 6 months after treatment completion 4
Sleep Hygiene Recommendations
As part of CBT-I, advise patients to:
- Maintain stable bed and wake times
- Avoid daytime napping (limit to 30 minutes if needed, not after 2pm)
- Avoid caffeine, nicotine, and alcohol
- Avoid heavy exercise within 2 hours of bedtime
- Use the bedroom only for sleep and sex
- Leave the bedroom if unable to fall asleep within 20 minutes 2
Second-Line Treatment: Pharmacological Options
If CBT-I alone is unsuccessful, the American College of Physicians recommends a shared decision-making approach to consider adding short-term medication 1:
Medication options to consider:
- Non-benzodiazepine hypnotics: Zolpidem (5-10mg), limited to short-term use (≤4 weeks) 2
- Doxepin: Low-dose for sleep maintenance insomnia 2
- Suvorexant: Orexin antagonist with moderate-quality evidence for improved treatment response 1
- Ramelteon: May decrease sleep onset latency in older adults 1
Important considerations:
- Discuss benefits, harms, and costs of short-term medication use
- Evidence on harms from RCTs is limited, but observational studies show hypnotics may be associated with serious adverse effects including dementia, injury, and fractures 1
- FDA labels warn of daytime impairment, "sleep driving," behavioral abnormalities
- Commonly used medications like diphenhydramine and trazodone have not been well-studied 1
Special Populations
Older Adults
- CBT-I is still first-line and shows benefits in this population 1, 2
- If medications are needed, use lower doses and shorter durations
- The American Geriatrics Society recommends using pharmacologic treatments with caution due to risks of tolerance and dependence 2
Patients with Comorbidities
- For patients with anxiety, short-acting benzodiazepines or lower-dose zolpidem may be considered 2
- For patients with depression, sedating antidepressants like trazodone or mirtazapine may be effective 2
Follow-Up and Monitoring
- Schedule follow-up within 2-4 weeks of any intervention 2
- Assess treatment response using standardized tools
- Evaluate for side effects if medications were prescribed
- Consider referral to sleep specialist if symptoms persist despite appropriate treatment 2
Common Pitfalls to Avoid
- Jumping to pharmacological treatment before trying CBT-I
- Prolonged use of sleep medications beyond recommended durations
- Failing to address underlying medical or psychiatric conditions
- Overlooking the importance of consistent sleep schedules
- Not providing adequate time for CBT-I to demonstrate effectiveness